ST Segment Resolution After Primary Percutaneous Coronary Intervention.
STresolution
SsST Segment Resolution After Primary Percutaneous Coronary Intervention. A Comparison Between Primary Percutaneous Coronary Intervention With and Without Thrombus Aspiration
1 other identifier
observational
270
0 countries
N/A
Brief Summary
To compare the ST segment resolution after primary percutaneous coronary intervention (PPCI) with and without thrombus aspiration in patients with ST segment elevation myocardial infarction as ST segment resolution is the best indicator for the prediction of the outcome and MACE
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2019
CompletedFirst Posted
Study publicly available on registry
March 29, 2019
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedMarch 29, 2019
March 1, 2019
1 year
March 24, 2019
March 28, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
ST segment resolution
ST segment resolution in relation to the procedure used in primary percutaneous coronary intervention
Within 90 minutes after the procedure
Secondary Outcomes (1)
MACE
one week
Study Arms (2)
Thrombus aspiration group
Will include 135 patients who will have PPCI with thrombus aspiration
Standard PPCI group
Will include 135 patients who will have PPCI without thrombus aspiration
Interventions
Percutaneous primary coronary intervention
Eligibility Criteria
270 patients
You may qualify if:
- patients with STEMI within 24 hours of chest pain.patients killip class 1 is included in this study
- xclusion Criteria:
- killip II-IV
- Previous myocardial infarction
- Patients with left bundle branch block
- Patients with advanced cancer disease
- Patients qith contraindications to anti-coagulation
- Patients with sensitivity to clopidogrel
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 24, 2019
First Posted
March 29, 2019
Study Start
September 1, 2019
Primary Completion
September 1, 2020
Study Completion
September 1, 2021
Last Updated
March 29, 2019
Record last verified: 2019-03